Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutationsLisa R. Forbes, Jennifer W. Leiding, Helen C. Su et al.|Journal of Allergy and Clinical Immunology|2018Cited by 261
Mutations in topoisomerase IIβ result in a B cell immunodeficiencyLori Broderick, Hal M. Hoffman, Shawn Yost et al.|Nature Communications|2019Cited by 58
Outcomes of Neonates Born to Mothers With Coronavirus Disease 2019 (COVID-19) — National Neonatology Forum (NNF) India COVID-19 RegistryVaanathi Vijayakumar, Praveen Kumar, Kiran More et al.|Indian Pediatrics|2021Cited by 52
Long-term safety of facilitated subcutaneous immunoglobulin 10% treatment in patients with primary immunodeficiency diseases: final analysis from a post-authorization safety study conducted in the USAArye Rubinstein, Leman Yel, Mohsen Mabudian et al.|Clinical Immunology|2023Cited by 1